提高临床血脂控制达标率的专家建议
万方数据
万方数据
万方数据
万方数据
万方数据
提高临床血脂控制达标率的专家建议
作者：中国临床血脂控制达标行动专家组， China Initiative on Clinical Control of
Oyslipidemia Expert Group
作者单位：
刊名：
中华心血管病杂志
英文刊名：CHINESE JOURNAL OF CARDIOLOGY
年，卷(期)：2010,38(4)
被引用次数：2次
参考文献(38条)
1.Keys A Coronary heart disease in seven countries 1970(Suppl 1)
2.中国成人血脂异常防治指南制订联合会中国成人血脂异常防治指南 2007
3.赵连成;梁立荣;陈祚我国高胆固醇血症患者临床控制状况变化趋势 2007
4.Cannon CP;Braunwald E;McCabe CH Intensive versus moderate lipid lowering with statins after acute coronary syndrome 2004
5.Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals:a randomised placebo-controlled trial 2002
6.Nakamura H;Arakawa K;Itakura H Primary prevention of cardiovascular disease with pravastatin in Japan(MEGA Study):a prospective randomized controlled trial 2006
7.Casebeer LL;Klapow JC;Centor RM An intervention to increase physicians' use of adherence-enhancing strategies in managing hypercholesterolemic patients 1999
8.Stamos TD;Shaltoni H;Girard SA Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program Guidelines 2001
9.卫生部统计信息中心2008年中国卫生年鉴 2009
10.中华人民共和国国家统计局中华人民共和国2008年国民经济和社会发展统计公报 2009
11.鄢盛恺应进一步加强血脂检验与临床的联系[期刊论文]-临床检验杂志 2008(4)
12.Lopez VA;Franklin SS;Tang S Coronary heart disease events preventable by control of blood pressure and lipids in U.S.adults with hypertension 2007
13.Stefanick ML;Mackey S;Sheehan M Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol 1998
14.Stout RW Insulin and atheroma:20-year perapective 1990
15.Wilson PW;Anderson KM;Castelli WP Twelve-year incidence of coronary heart disease in middie aged adults during the era of hypertensive therapy:the Framingham Offspring Study 1991
16.Assmnan G;Cullen P;Schulte H The Munster Heart Study (PROCAM):results of follow-up at 8 years 1998(Suppl A)
17.Verschuren WM;Jacobs DR;Bloemberg BP Serum total cholesterol and long-term coronary heart disease mortality in different cultures.Twenty-five-year follow-up of the Seven Countries Study 1995
18.第二次中国临床血脂控制现状多中心协作研究组第二次中国临床血脂控制达标率及影响因素多中心协作研究2007
19.《中华心血管病杂志》编委会血脂异常防治对策专题组血脂异常防治建议 1997
20.Kreisberg RA Diabetic dyslipidemia 1998
21.他汀类药物预防缺血性卒中/短暂性脑缺血发作专家组他汀类药物预防缺血性卒中/短暂性脑缺血发作的专家建议[期刊论文]-中华内科杂志 2007(1)
22.Manktelow BN;Potter JF Interventions in the management of serum lipids for preventing stroke recurrence 2009(03)
23.Ballantyne CM;Blazing MA;King TR Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hyperoholesterolemia 2004
https://www.wendangku.net/doc/bf18816706.html,w M;Rudnicka AR Statin safety:a systematic review 2006
25.de Lemos JA;Blazing MA;Wiviott SD Early intensive vs a delayed conservative simvastatin strateSy in patients with acute coronary syndromes:phase Z of the A to Z trial 2004
26.Schwartz GG;Olsson AG;Ezekowitz MD Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes:the MIRACL study:a randomized controlled trial 2001
27.Pederson TB;Faergeman O;Kastelein JJ High-dose atorvastetin vs usual-dose simvastin for secondary prevention after myocardial infarction:the IDEAL study:a randomised controlled trial 2005
https://www.wendangku.net/doc/bf18816706.html,rosa JC;Grundy SM;Waters DD Intensive lipid lowering with atorvastatin in patients with stable coronary disease[外文期刊] 2005(14)
29.Pitt B;Waters D;Brown WV Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease 1999
30.Downs JR;Clearfield M;Weis S Primary prevention of acute coronary events witl lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS 1998
31.Shepherd J;Cobbe SM;Ford I Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia 1995
32.血脂康调整血脂对冠心病二级预防研究协作组中国冠心病二级预防研究[期刊论文]-中华心血管病杂志
2005(2)
33.The long-term intervention with pravastatin in ischaemic disease (LIPID)study group Prevention of cardiovascular events and death wlth pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels 1998
34.Sacks FM;Pfeffer MA;Moye LA The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels 1996
35.The Scandinavian Simvastetin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian simvastatin survival study(4S) 1994 36.李莹;陈志红;周北凡血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[期刊论文]-中华心血管病杂志 2004(7)
37.刘静;赵冬;吴兆苏低密度脂蛋白水平与心血管病发病关系的前瞻性研究 2001
38.全国高胆固醇血症控制状况多中心研究协作组高胆固醇血症控制状况多中心协作研究 2002
引证文献(2条)
1.朱彩霞阿托伐他汀治疗高血压合并冠心病的临床观察[期刊论文]-中国医学创新 2011(5)
2.鄢盛恺.柯元南.李珅珅.姜红.李江.杨辉.武阳丰相关科室血脂异常患者对检验报告单有用性评价及调脂治疗相关知识调查[期刊论文]-北京大学学报(医学版) 2010(6)
本文链接：https://www.wendangku.net/doc/bf18816706.html,/Periodical_zhxxgb201004004.aspx